Pharvaris Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - Zug, Switzerland
Description - Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. Learn more...
Tags - HAE PHVS416 PHA121 Phase 2
Team
Founder Berndt Modig
Funding
Pharvaris raised $80,000,000 with Viking Global Investors and General Atlantic and Cormorant Asset Management, Foresite Capital, Venrock Healthcare Capital Partners, Bain Capital Life Sciences - 11/18/2020